• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4833126)   Today's Articles (5700)
For: Das S, Dasari A. Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences? Curr Oncol Rep 2021;23:43. [PMID: 33719003 DOI: 10.1007/s11912-021-01029-7] [Citation(s) in RCA: 179] [Impact Index Per Article: 44.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/18/2021] [Indexed: 12/17/2022]
Number Cited by Other Article(s)
1
Xu J, Shen L, Li J, Zhou Z, Bai C, Li Z, Chi Y, Li E, Yu X, Xu N, Bai Y, Wang X, Yuan X, Liu T, Yin Y, Chen J, Hu H, Li X, Xiu D, Zhang T, Lou W, Ying J, Qin S, Deng Y, Tao M, Cheng Y, Fan S, Luo X, Guo X, Shi MM, Su W. Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p). Eur J Cancer 2025;222:115398. [PMID: 40306120 DOI: 10.1016/j.ejca.2025.115398] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2025] [Revised: 03/19/2025] [Accepted: 03/22/2025] [Indexed: 05/02/2025]
2
Morthy P, Musarudin M, Shukor NSA, Said MA, Xianling D, Saripan MI. Accuracy of 177Lu activity quantification using MCNP5-Modeled SPECT imaging. Appl Radiat Isot 2025;220:111786. [PMID: 40121923 DOI: 10.1016/j.apradiso.2025.111786] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2024] [Revised: 02/19/2025] [Accepted: 03/15/2025] [Indexed: 03/25/2025]
3
Satapathy S, Aggarwal P, Sood A, Chandekar KR, Das CK, Gupta R, Khosla D, Das N, Kapoor R, Kumar R, Singh H, Mittal BR. Novel framework for response evaluation criteria in grade 1/2 neuroendocrine tumors (RECIN) following [177Lu]Lu-DOTATATE therapy: post-hoc analysis of the phase 2 LuCAP trial. Eur J Nucl Med Mol Imaging 2025:10.1007/s00259-025-07351-7. [PMID: 40414996 DOI: 10.1007/s00259-025-07351-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2025] [Accepted: 05/12/2025] [Indexed: 05/27/2025]
4
Nwoguh CA, Asmar ME, Mortagy M, Srirajaskanthan R, Russell B, White BE, Chandrakumaran K, Ramage JK. The geographical distribution of neuroendocrine neoplasms in England (2012-2018). J Neuroendocrinol 2025:e70038. [PMID: 40404336 DOI: 10.1111/jne.70038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/16/2025] [Revised: 04/03/2025] [Accepted: 04/15/2025] [Indexed: 05/24/2025]
5
Meyers M, Karfis I, Hendlisz A. Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms? Curr Opin Oncol 2025:00001622-990000000-00261. [PMID: 40422736 DOI: 10.1097/cco.0000000000001158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2025]
6
Fawzy MS, Alenezy A, Jishu JA, Khan I, Dessouky A, Abdelmaksoud A, Limbach KE, Toraih EA. Survival Benefits of GLP-1 Receptor Agonists in Patients with Neuroendocrine Neoplasms: A Large-Scale Propensity-Matched Cohort Study. Cancers (Basel) 2025;17:1593. [PMID: 40361517 PMCID: PMC12072167 DOI: 10.3390/cancers17091593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2025] [Revised: 05/04/2025] [Accepted: 05/06/2025] [Indexed: 05/15/2025]  Open
7
Flicek KT, Nehra AK, Fidler JL, Sheedy SP. Imaging of the Small Bowel Tumors. Radiol Clin North Am 2025;63:345-359. [PMID: 40221179 DOI: 10.1016/j.rcl.2024.11.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/14/2025]
8
Lodato F, Gazzola A, Signoretti M, Mastrangelo L, Gaetani L, Landi S, Puglisi SB, Jovine E, Cennamo V. Impact of multidisciplinary discussion on pancreatic neuroendocrine tumours, experience of a tertiary centre. Eur J Gastroenterol Hepatol 2025:00042737-990000000-00530. [PMID: 40359293 DOI: 10.1097/meg.0000000000002997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/15/2025]
9
Feldman D, Rodgers-Fouche LH, Ukaegbu C, Yurgelun MB, Syngal S, Chung DC. Cancer Incidence and Mortality in Familial Adenomatous Polyposis Syndrome. Dis Colon Rectum 2025;68:531-543. [PMID: 39932215 DOI: 10.1097/dcr.0000000000003645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/17/2025]
10
Ni JK, Ling ZL, Liang X, Song YH, Zhang GM, Chen CX, Wang LM, Wang P, Li GC, Ma SY, Gao J, Chang L, Zhang XX, Zhong N, Li Z. A convolutional neural network-based system for identifying neuroendocrine neoplasms and multiple types of lesions in the pancreas using EUS (with videos). Gastrointest Endosc 2025;101:1020-1029.e3. [PMID: 39424005 DOI: 10.1016/j.gie.2024.10.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/10/2024] [Revised: 10/04/2024] [Accepted: 10/08/2024] [Indexed: 10/21/2024]
11
Lopez-Ramirez F, Yasrab M, Tixier F, Kawamoto S, Fishman EK, Chu LC. The Role of AI in the Evaluation of Neuroendocrine Tumors: Current State of the Art. Semin Nucl Med 2025;55:345-357. [PMID: 40023682 DOI: 10.1053/j.semnuclmed.2025.02.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2025] [Accepted: 02/07/2025] [Indexed: 03/04/2025]
12
Nordstrand MA, Lea D, Søreide JA. Incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): An updated systematic review of population-based reports from 2010 to 2023. J Neuroendocrinol 2025;37:e70001. [PMID: 39933712 DOI: 10.1111/jne.70001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/15/2024] [Revised: 12/28/2024] [Accepted: 01/28/2025] [Indexed: 02/13/2025]
13
Wen I, Kim LH, Wong M, di Lernia S, Maclean F, Lee A, Lee A, Ganapathy A, Chan D. Renal mucinous cystadenoma in the context of lynch syndrome and colonic neuroendocrine neoplasm: a case report. Oxf Med Case Reports 2025;2025:omaf012. [PMID: 40162154 PMCID: PMC11952886 DOI: 10.1093/omcr/omaf012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2024] [Revised: 12/26/2024] [Accepted: 01/26/2025] [Indexed: 04/02/2025]  Open
14
Sahu A, Patlas M, Jajodia A. The radiologic spectrum of neuroendocrine tumors in emergent care. Rev Endocr Metab Disord 2025;26:175-186. [PMID: 39745542 DOI: 10.1007/s11154-024-09940-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 12/29/2024] [Indexed: 03/19/2025]
15
Spada F, Rossi RE, Modica R, Gelsomino F, Rinzivillo M, Rubino M, Pisa E, La Salvia A, Fazio N. Functioning neuroendocrine tumors (NET): Minimum requirements for a NET specialist. Cancer Treat Rev 2025;135:102907. [PMID: 40023966 DOI: 10.1016/j.ctrv.2025.102907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2024] [Revised: 02/22/2025] [Accepted: 02/24/2025] [Indexed: 03/04/2025]
16
Htoo A, Arker SH, George RS, Chung L, Chen A. Utility of the manual hematology cell counter for Ki-67 assessment in gastrointestinal and pancreatobiliary well-differentiated neuroendocrine tumors. Ann Diagn Pathol 2025;75:152443. [PMID: 39908656 DOI: 10.1016/j.anndiagpath.2025.152443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2025] [Accepted: 01/21/2025] [Indexed: 02/07/2025]
17
Padwal MK, Nazar AK, Parghane RV, Basu S, Basu B. Evaluating the prognostic significance of the pre-treatment neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios in 177Lu-DOTATATE PRRT treated patients with advanced metastatic neuroendocrine tumors. Endocrine 2025:10.1007/s12020-025-04212-z. [PMID: 40131599 DOI: 10.1007/s12020-025-04212-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/09/2025] [Accepted: 03/13/2025] [Indexed: 03/27/2025]
18
Tixier F, Lopez-Ramirez F, Blanco A, Javed AA, Chu LC, Hruban RH, Yasrab M, Fouladi DF, Shayesteh S, Ghandili S, Fishman EK, Kawamoto S. Diagnostic Performance of Combined Conventional CT Imaging Features and Radiomics Signature in Differentiating Grade 1 Tumors from Higher-Grade Pancreatic Neuroendocrine Neoplasms. Cancers (Basel) 2025;17:1047. [PMID: 40149380 PMCID: PMC11941307 DOI: 10.3390/cancers17061047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2025] [Revised: 03/16/2025] [Accepted: 03/18/2025] [Indexed: 03/29/2025]  Open
19
von Hessert-Vaudoncourt C, Maasberg S, Begum N, Rinke A, Pöppel T, Sipos B, Grohe C, Fottner C, Stintzing S, Grabowski P. Clinical characteristics and treatment patterns of patients with gastroenteropancreatic neuroendocrine neoplasia in Germany receiving peptide receptor radionuclide therapy: A real-world data registry-based study. Medicine (Baltimore) 2025;104:e41853. [PMID: 40101049 PMCID: PMC11922424 DOI: 10.1097/md.0000000000041853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/13/2024] [Accepted: 02/25/2025] [Indexed: 03/20/2025]  Open
20
Chen JS, Bai LY, Cheng HH, Chan SL, Zou JY, Shi X, Houchard A, Truong-Thanh XM, Chen MH. Real-World Study of Lanreotide Autogel in Routine Practice in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Hong Kong and Taiwan. Oncol Ther 2025;13:69-83. [PMID: 39215958 PMCID: PMC11880440 DOI: 10.1007/s40487-024-00302-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2024] [Accepted: 08/15/2024] [Indexed: 09/04/2024]  Open
21
Padwal MK, Parghane RV, Chakraborty A, Ujaoney AK, Anaganti N, Basu S, Basu B. Developing a peripheral blood RNA-seq based NETseq ensemble classifier: A potential novel tool for non-invasive detection and treatment response assessment in neuroendocrine tumor patients receiving 177Lu-DOTATATE PRRT. J Neuroendocrinol 2025;37:e13462. [PMID: 39539072 PMCID: PMC11919474 DOI: 10.1111/jne.13462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/03/2024] [Revised: 09/12/2024] [Accepted: 10/24/2024] [Indexed: 11/16/2024]
22
Alexandraki KI, Papadimitriou E, Spyroglou A, Karapanagioti A, Antonopoulou I, Theohari I, Violetis O, Sotiropoulos GC, Theocharis S, Kaltsas GA. Immunohistochemical expression of ephrin receptors in neuroendocrine neoplasms: a case-series of gastroenteropancreatic neuroendocrine neoplasms and a systematic review of the literature. Endocrine 2025;87:1323-1332. [PMID: 39425842 DOI: 10.1007/s12020-024-04079-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/10/2024] [Accepted: 10/10/2024] [Indexed: 10/21/2024]
23
Puranik AD, Dev ID, Prasad V. Frontiers in radiopharmaceuticals for neuroendocrine tumors. J Neuroendocrinol 2025;37:e70006. [PMID: 39961670 DOI: 10.1111/jne.70006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/07/2024] [Revised: 01/30/2025] [Accepted: 01/31/2025] [Indexed: 03/20/2025]
24
Bao X, Li S, Yao S, Chen Q. Research process of PET tracers for neuroendocrine tumors diagnosis. AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 2025;15:1-14. [PMID: 40124763 PMCID: PMC11929009 DOI: 10.62347/jxly1661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/22/2025] [Accepted: 02/14/2025] [Indexed: 03/25/2025]
25
Ranallo N, Roncadori A, Gentili N, Balzi W, Altini M, Ghini V, Maltoni R, Andalò A, Cavallucci M, Sansovini M, Fausti V, Montella MT, Massa I, Danesi V. Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study. Biomedicines 2025;13:515. [PMID: 40002928 PMCID: PMC11852996 DOI: 10.3390/biomedicines13020515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2025] [Revised: 02/14/2025] [Accepted: 02/17/2025] [Indexed: 02/27/2025]  Open
26
Massironi S, Panzuto F, Zilli A, Rinzivillo M, Ciliberto A, Romano E, Danese S, Laviano A. Nutritional aspects in neuroendocrine neoplasms. bridging the gap between dietary interventions and cancer care strategies: a scoping review. J Endocrinol Invest 2025;48:269-281. [PMID: 39395115 PMCID: PMC11785655 DOI: 10.1007/s40618-024-02462-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/11/2024] [Accepted: 08/26/2024] [Indexed: 10/14/2024]
27
Awali M, El Homsi M, Fraum TJ, Shetty AS, Ponisio MR, Gharzeddine K, Mhlanga J, Mallak N, Behr S, Itani M. PET/MRI: pictorial review of hepatobiliary and pancreatic applications. Abdom Radiol (NY) 2025;50:875-901. [PMID: 39254711 DOI: 10.1007/s00261-024-04548-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2024] [Revised: 08/20/2024] [Accepted: 08/25/2024] [Indexed: 09/11/2024]
28
Hallet J, Shapiro J, Pascher A, Gaujoux S, Gangi A, Dominguez-Rosado I, Falconi M, Partelli S. Care of neuroendocrine tumours: the Collaborative of sUrgical Teams for NeuroEndocrine Tumors (CUTNETs). Br J Surg 2025;112:znae317. [PMID: 39907658 DOI: 10.1093/bjs/znae317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2024] [Accepted: 12/09/2024] [Indexed: 02/06/2025]
29
Kenney LM, Hughes M. Surgical Management of Gastroenteropancreatic Neuroendocrine Tumors. Cancers (Basel) 2025;17:377. [PMID: 39941746 PMCID: PMC11816225 DOI: 10.3390/cancers17030377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2024] [Revised: 01/17/2025] [Accepted: 01/22/2025] [Indexed: 02/16/2025]  Open
30
Mukherjee S, Pattnaik H, Sonti S, Ramesh M, Jain P, Ramirez RA, Fountzilas C, Vadehra D, Attwood K, Iyer R. Phase II Study of Nanoliposomal Irinotecan (Nal-IRI) with 5-Fluorouracil and Leucovorin in Refractory Advanced High-Grade Neuroendocrine Cancer of Gastroenteropancreatic (GEP) or Unknown Origin. Cancers (Basel) 2025;17:224. [PMID: 39858006 PMCID: PMC11763628 DOI: 10.3390/cancers17020224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2024] [Revised: 01/06/2025] [Accepted: 01/10/2025] [Indexed: 01/27/2025]  Open
31
Lei X, Su Y, Lei R, Zhang D, Liu Z, Li X, Yang M, Pei J, Chi Y, Song L. Predictive and prognostic nomogram models for liver metastasis in colorectal neuroendocrine neoplasms: a large population study. Front Endocrinol (Lausanne) 2025;15:1488733. [PMID: 39839478 PMCID: PMC11746099 DOI: 10.3389/fendo.2024.1488733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/30/2024] [Accepted: 12/06/2024] [Indexed: 01/23/2025]  Open
32
Ozsoy MS, Erol CI, Aydemir MA, Baysal H, Buyuker F, Seneldir H, Ekinci O, Eren T, Alimoglu O. Gastroenteropancreatic Neuroendocrine Tumors: Does Tumor Location Affect Prognosis? ARCHIVES OF IRANIAN MEDICINE 2025;28:29-39. [PMID: 40001327 PMCID: PMC11862391 DOI: 10.34172/aim.33366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/27/2024] [Accepted: 11/11/2024] [Indexed: 02/27/2025]
33
Metzcar J, Guenter R, Wang Y, Baker KM, Lines KE. Improving neuroendocrine tumor treatments with mathematical modeling: lessons from other endocrine cancers. ENDOCRINE ONCOLOGY (BRISTOL, ENGLAND) 2025;5:e240025. [PMID: 39949335 PMCID: PMC11825163 DOI: 10.1530/eo-24-0025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/23/2024] [Revised: 11/11/2024] [Accepted: 01/08/2025] [Indexed: 02/16/2025]
34
Park HM, Kang MJ, Park SJ, Jung KW, Han SS. Epidemiology and survival analysis according to the histologic subtype of pancreatic cancer: a population-based cohort study. Ann Surg Treat Res 2025;108:20-30. [PMID: 39823040 PMCID: PMC11735170 DOI: 10.4174/astr.2025.108.1.20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2024] [Revised: 10/31/2024] [Accepted: 10/31/2024] [Indexed: 01/19/2025]  Open
35
Panzuto F, Albertelli M, De Rimini ML, Rizzo FM, Grana CM, Cives M, Faggiano A, Versari A, Tafuto S, Fazio N, Colao A, Scalorbi F, Ferone D, Cinieri S, Maccauro M. Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM). J Endocrinol Invest 2025;48:23-36. [PMID: 39395114 PMCID: PMC11729074 DOI: 10.1007/s40618-024-02448-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/19/2024] [Accepted: 07/13/2024] [Indexed: 10/14/2024]
36
Gao Y, Zheng H, Ye M, Zhou G, Chen J, Qiang X, Bai J, Lu X, Tang Q. Characteristics and function of the gut microbiota in patients with rectal neuroendocrine tumors. J Cancer 2025;16:1040-1050. [PMID: 39895797 PMCID: PMC11786048 DOI: 10.7150/jca.103297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2024] [Accepted: 12/01/2024] [Indexed: 02/04/2025]  Open
37
Meng QH, Halfdanarson TR, Bornhorst JA, Jann H, Shaheen S, Shi RZ, Schwabe A, Stade K, Halperin DM. Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study. Clin Cancer Res 2024;30:5559-5567. [PMID: 39453770 DOI: 10.1158/1078-0432.ccr-24-1875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2024] [Revised: 08/09/2024] [Accepted: 10/23/2024] [Indexed: 10/27/2024]
38
Tan WY, Cramer LD, Vijayvergia N, Lustberg M, Kunz PL. Impact of sex differences on patients with neuroendocrine neoplasms during hospital admission. Ther Adv Med Oncol 2024;16:17588359241292271. [PMID: 39687054 PMCID: PMC11648047 DOI: 10.1177/17588359241292271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2024] [Accepted: 10/02/2024] [Indexed: 12/18/2024]  Open
39
Chapeau D, Beekman S, Piet A, Li L, de Ridder C, Stuurman D, Seimbille Y. eSOMA-DM1, a Maytansinoid-Based Theranostic Small-Molecule Drug Conjugate for Neuroendocrine Tumors. Bioconjug Chem 2024;35:1823-1834. [PMID: 39395152 DOI: 10.1021/acs.bioconjchem.4c00413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2024]
40
Sato H, Fujii S, Okada T, Kawabata H, Kamikokura Y, Fujiya M. Small Insulinoma Followed-up as an Indolent Pancreatic Tumor. Intern Med 2024;63:2929-2937. [PMID: 38432990 PMCID: PMC11604390 DOI: 10.2169/internalmedicine.3194-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/13/2023] [Accepted: 01/21/2024] [Indexed: 03/05/2024]  Open
41
Mulders MCF, Verschuur AVD, de Lussanet de la Sablonière QG, Roes EM, Geisenberger C, Brosens LAA, de Herder WW, van Velthuysen MF, Hofland J. Clinicopathological and epigenetic differences between primary neuroendocrine tumors and neuroendocrine metastases in the ovary. J Pathol Clin Res 2024;10:e70000. [PMID: 39513463 PMCID: PMC11544441 DOI: 10.1002/2056-4538.70000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2024] [Revised: 07/31/2024] [Accepted: 08/19/2024] [Indexed: 11/15/2024]
42
Frydman A, Srirajaskanthan R. An Update on the Management of Rectal Neuroendocrine Neoplasms. Curr Treat Options Oncol 2024;25:1461-1470. [PMID: 39476215 PMCID: PMC11541365 DOI: 10.1007/s11864-024-01267-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/24/2024] [Indexed: 11/07/2024]
43
Sawaf B, Abbarh S, Ahmed AI, Halabiya M, Ismail A, Mezhoud S. Small bowel neuroendocrine tumor presenting with chronic diarrhea and mesenteric ischemia: A case report. Clin Case Rep 2024;12:e9508. [PMID: 39493797 PMCID: PMC11527732 DOI: 10.1002/ccr3.9508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2024] [Revised: 08/05/2024] [Accepted: 09/16/2024] [Indexed: 11/05/2024]  Open
44
Liu Y, Yang X, Wang Y, Xie S, Li M, You J, Tang Y, Zhao J, Weng D. Efficacy and safety of surufatinib in the treatment of patients with neuroendocrine tumor: a real-world study in Chinese population. BMC Cancer 2024;24:1342. [PMID: 39482595 PMCID: PMC11529162 DOI: 10.1186/s12885-024-13089-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2024] [Accepted: 10/23/2024] [Indexed: 11/03/2024]  Open
45
Viswanathan D, Govindasamy R. Commentary: treatment indicators and prognostic factors in colorectal neuroendocrine neoplasms and adenocarcinoma with neuroendocrine differentiation. Int J Colorectal Dis 2024;39:176. [PMID: 39482390 PMCID: PMC11527906 DOI: 10.1007/s00384-024-04754-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 10/28/2024] [Indexed: 11/03/2024]
46
Durma AD, Saracyn M, Kołodziej M, Jóźwik-Plebanek K, Brodowska-Kania D, Dmochowska B, Mróz A, Kos-Kudła B, Kamiński G. Adverse Events of Radioligand Therapy in Patients with Progressive Neuroendocrine Neoplasms: The Biggest Eastern European Prospective Study. Cancers (Basel) 2024;16:3509. [PMID: 39456603 PMCID: PMC11505743 DOI: 10.3390/cancers16203509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2024] [Revised: 10/14/2024] [Accepted: 10/15/2024] [Indexed: 10/28/2024]  Open
47
Massironi S. Unraveling the Microbiome's Role in Neuroendocrine Neoplasms: A New Perspective. Neuroendocrinology 2024;114:977-980. [PMID: 39406190 DOI: 10.1159/000541678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/26/2024] [Accepted: 09/26/2024] [Indexed: 11/12/2024]
48
Maluchenko A, Maksimov D, Antysheva Z, Krupinova J, Avsievich E, Glazova O, Bodunova N, Karnaukhov N, Feidorov I, Salimgereeva D, Voloshin M, Volchkov P. Molecular Basis of Pancreatic Neuroendocrine Tumors. Int J Mol Sci 2024;25:11017. [PMID: 39456803 PMCID: PMC11507569 DOI: 10.3390/ijms252011017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2024] [Revised: 09/20/2024] [Accepted: 09/21/2024] [Indexed: 10/28/2024]  Open
49
Santos AP. All Neuroendocrine Tumors Seem to Look Alike but Some Look Alike More Than Others. GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY 2024;31:303-305. [PMID: 39360173 PMCID: PMC11444703 DOI: 10.1159/000539161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/03/2024] [Accepted: 04/25/2024] [Indexed: 10/04/2024]
50
Tan B, Zhang B, Chen H. Gastroenteropancreatic neuroendocrine neoplasms: epidemiology, genetics, and treatment. Front Endocrinol (Lausanne) 2024;15:1424839. [PMID: 39411312 PMCID: PMC11474919 DOI: 10.3389/fendo.2024.1424839] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/15/2024] [Accepted: 09/10/2024] [Indexed: 10/19/2024]  Open
PrevPage 1 of 4 1234Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA